MedTrace Logo

Bioavailability Study of COQUN ORAL FORMULATION

NCT03819491 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2019-09-06

Study results available
· View outcomes & findings →

Summary

The goal of the study is to evaluate the best dosage for COQUN ORAL FORMULATION in order to reach a level of plasma concentration which might assure its antioxidant effect if taken on a regular basis.

Conditions

  • Male & Female Healthy Volunteers

Interventions

DIETARY_SUPPLEMENT

COQUN ORAL FORMULATION

COQUN ORAL FORMULATION is a food supplement based on Coenzyme Q10 MINIACTIVES®

Sponsors & Collaborators

  • VISUfarma SpA

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-22
Primary Completion
2018-08-29
Completion
2018-08-29

Countries

  • Romania

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03819491 on ClinicalTrials.gov